Unichem Laboratories, a leading pharmaceutical company in India, announced that it has received ANDA approval from the United States Food and Drug Administration (USFDA) for Donepezil Hydrochloride Tablets USP.

Donepezil Hydrochloride Tablets USP 5mg and 10mg are therapeutically equivalent to Aricept Tablets, 5mg and 10mg of Eisai, Inc. (USA). Donepezil Hydrochloride is a reversible inhibitor of the enzyme acetylcholinesterase which is used to improve cognition and behavior of people with Alzheimer's, but does not slow the progression of or cure the disease.

The product will be commercialized from Unichem’s Goa plant. Active Pharmaceutical Ingredient will also be made in house at Roha API Plant.

Unichem Laboratories Limited now has total of 21 molecules approved from USFDA.

Shares of the company declined Rs 11.1, or 4.08%, to trade at  Rs 261.00.  The total volume of shares traded  was  32,289 at the BSE (1.10 p.m., Friday).